Cite
Predictive value of elevated neutrophil gelatinase-associated lipocalin levels for assessment of in-hospital adverse outcomes among myocardial infarction patients.
MLA
Ziv-Baran, Tomer, et al. “Predictive Value of Elevated Neutrophil Gelatinase-Associated Lipocalin Levels for Assessment of in-Hospital Adverse Outcomes among Myocardial Infarction Patients.” Coronary Artery Disease, vol. 34, no. 6, Sept. 2023, pp. 389–94. EBSCOhost, https://doi.org/10.1097/MCA.0000000000001261.
APA
Ziv-Baran, T., Frydman, S., Khoury, S., Itach, T., Banai, S., & Shacham, Y. (2023). Predictive value of elevated neutrophil gelatinase-associated lipocalin levels for assessment of in-hospital adverse outcomes among myocardial infarction patients. Coronary Artery Disease, 34(6), 389–394. https://doi.org/10.1097/MCA.0000000000001261
Chicago
Ziv-Baran, Tomer, Shir Frydman, Shafik Khoury, Tamar Itach, Shmuel Banai, and Yacov Shacham. 2023. “Predictive Value of Elevated Neutrophil Gelatinase-Associated Lipocalin Levels for Assessment of in-Hospital Adverse Outcomes among Myocardial Infarction Patients.” Coronary Artery Disease 34 (6): 389–94. doi:10.1097/MCA.0000000000001261.